BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22770934)

  • 21. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
    Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
    Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis.
    Cappelli F; Baldasseroni S; Bergesio F; Padeletti L; Attanà P; Pignone AM; Grifoni E; Ciuti G; Fabbri A; Tarantini F; Marchionni N; Gensini GF; Perfetto F
    Amyloid; 2014 Jun; 21(2):97-102. PubMed ID: 24517408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
    Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
    Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
    Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
    J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis.
    Mohty D; Pibarot P; Dumesnil JG; Darodes N; Lavergne D; Echahidi N; Virot P; Bordessoule D; Jaccard A
    Arch Cardiovasc Dis; 2011 Dec; 104(12):611-8. PubMed ID: 22152513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac amyloidosis without increased left ventricular wall thickness.
    Lee GY; Kim K; Choi JO; Kim SJ; Kim JS; Choe YH; Grogan MA; Jeon ES
    Mayo Clin Proc; 2014 Jun; 89(6):781-9. PubMed ID: 24702732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.
    Kristen AV; Brokbals E; Aus dem Siepen F; Bauer R; Hein S; Aurich M; Riffel J; Behrens HM; Krüger S; Schirmacher P; Katus HA; Röcken C
    J Am Coll Cardiol; 2016 Jul; 68(1):13-24. PubMed ID: 27364045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Diastolic Strain Rate in Relation to Systolic and Diastolic Function and Prognosis in Aortic Stenosis.
    Dahl JS; Barros-Gomes S; Videbæk L; Poulsen MK; Issa IF; Carter-Storch R; Christensen NL; Kumme A; Pellikka PA; Møller JE
    JACC Cardiovasc Imaging; 2016 May; 9(5):519-28. PubMed ID: 27085434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide similar prognostic information in patients with systolic dysfunction after myocardial infarction.
    Pozzoli M; Capomolla S; Sanarico M; Pinna G; Cobelli F; Tavazzi L
    Am Heart J; 1995 Apr; 129(4):716-25. PubMed ID: 7900623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of B-type natriuretic peptide for estimating left ventricular filling pressures in unselected elderly patients undergoing diagnostic coronary angiography.
    Stolker JM; Rich MW
    J Invasive Cardiol; 2010 Mar; 22(3):107-12. PubMed ID: 20197576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
    Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
    JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
    Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
    Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients -  single center experience].
    Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
    Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain natriuretic peptide and other cardiac markers predicting left ventricular remodeling and function two years after myocardial infarction.
    Grybauskiene R; Karciauskaite D; Brazdzionyte J; Janenaite J; Bertasiene Z; Grybauskas P
    Medicina (Kaunas); 2007; 43(9):708-15. PubMed ID: 17986844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.
    Nagano N; Yano T; Fujita Y; Kouzu H; Koyama M; Ikeda H; Yasui K; Muranaka A; Nishikawa R; Takahashi R; Kishiue N; Yuda S; Miura T
    Heart Vessels; 2020 Apr; 35(4):521-530. PubMed ID: 31559459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.
    Milani P; Dispenzieri A; Scott CG; Gertz MA; Perlini S; Mussinelli R; Lacy MQ; Buadi FK; Kumar S; Maurer MS; Merlini G; Hayman SR; Leung N; Dingli D; Klarich KW; Lust JA; Lin Y; Kapoor P; Go RS; Pellikka PA; Hwa YL; Zeldenrust SR; Kyle RA; Rajkumar SV; Grogan M
    Circ Cardiovasc Imaging; 2018 May; 11(5):e006588. PubMed ID: 29752392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
    Koyama J; Falk RH
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):333-42. PubMed ID: 20394893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right ventricular function in AL amyloidosis: characteristics and prognostic implication.
    Cappelli F; Porciani MC; Bergesio F; Perlini S; Attanà P; Moggi Pignone A; Salinaro F; Musca F; Padeletti L; Perfetto F
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):416-22. PubMed ID: 22180463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.